Resources
83 Results (showing 31 - 40)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 9/18/2020 (updated 3/29/2024)
The National Alliance of State and Territorial AIDS Directors (NASTAD) hosted the Hepatitis A and Hepatitis B Vaccination Efforts in People Who Inject Drugs webinar last week, September 10, 2020. The session featured Centers for Disease Control and Prevention subject matter experts who discussed the epidemiology of hepatitis A and hepatitis B in people who use and inject drugs and the rationale for the vaccination recommendations. The session also featured several jurisdictions and partner organizations who shared their lessons learned and best practices for reaching and implementing vaccination services in this community.
Posted 10/5/2020 (updated 3/29/2024)
This review looks at evidence and program models for alternatives to hospitalization to treat serious infections in people who inject drugs.
Posted 10/12/2020 (updated 3/29/2024)
The present two-fold study “Speed Limits – Harm reduction for people who use stimulants” significantly contributes to closing the gap of knowledge about which existing harm reduction interventions are effective for people who use stimulant drugs.
Posted 10/12/2020 (updated 3/29/2024)
This resource provides a summary of HIV risk assessment, screening tests, screening intervals, and treatment and interventions for both adolescents and adults and pregnant persons.
Posted 10/12/2020 (updated 3/29/2024)
This report summarizes current (as of 2011) guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of human immunodeficiency virus (HIV) infection, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) for persons who use drugs illicitly.
Posted 10/12/2020 (updated 3/29/2024)
This article discusses findings from a study published in the Journal of Viral Hepatitis which addresses the question of HCV testing frequency in people who inject drugs.
Posted 10/28/2020 (updated 4/3/2024)
In this year 2 kickoff session, HRSA Project Officers will share reminders and updates about grant deliverables, the Evaluation Team will give updates, and Technical Expert Leads will discuss new and ongoing technical assistance available to Implementation I and MAT-Expansion grantees.
Posted 11/4/2020 (updated 4/3/2024)
The opioid crisis has disproportionally affected Appalachia. One of the potentially
lethal and costly complications associated with IV drug use is infective endocarditis (IE). The goal of this study was to assess the trend and costs of substance abuse associated IE admissions in Southern West Virginia.
Posted 11/9/2020 (updated 4/3/2024)
This webinar will provide an overview of racial and ethnic minority members of rural communities; describe the relationship between social determinants of health, health disparities, health equity, and rural racial and ethnic minority populations; and propose characteristics for an effective engagement and collaboration plan for working with these populations. The presenter will discuss strategies for enhancing engaging and collaborating with rural racial and ethnic minority populations and review available resources and tools.
Posted 11/10/2020 (updated 4/3/2024)
In the context of the trends in Oregon SUD metrics and the increasing infectious complications related to IDU in other jurisdictions and their implications for HIV and HCV transmission, we sought to 1) describe statewide trends in IDU-related serious bacterial infections (SBI) hospitalizations overall and by SBI type and drug use diagnosis, 2) assess IDU-related SBI diagnoses among individuals living with HIV and HCV, and 3) and determine the annual costs of IDU-related SBI overall and by SBI type.